March 04, 2026 a 07:43 am
BAX: Fundamental Ratio Analysis - Baxter International Inc.
Baxter International Inc. offers a diverse range of healthcare products globally. The recent fundamental analysis shows mixed results based on various financial metrics. Investors should consider both the risks and opportunities associated with this stock before making investment decisions.
Fundamental Rating
The fundamental ratings give a snapshot of Baxter International Inc.'s financial health and market valuation.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 3 |
Historical Rating
The historical data offers insight into how the company's metrics have changed over time.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2 | 5 | 1 | 1 | 1 | 1 | 3 |
| Previous | 0 | 5 | 1 | 1 | 1 | 1 | 3 |
Analysts' Price Targets
Analysts provide price targets to guide investor expectations.
| High | Low | Median | Consensus |
|---|---|---|---|
| $25 | $15 | $19.5 | $19.75 |
Analysts' Sentiment
The sentiment illustrates the proportion of different recommendations by analysts.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 20 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Baxter International Inc. presents a moderate investment opportunity with potential upsides in the healthcare sector. While the fundamental ratings indicate a mixed financial health, the majority of analysts suggest holding the stock. Investors should be cautious of the low returns on equity and assets, which may impact long-term growth. Current analyst price targets show limited room for appreciation, implying a neutral market position. Careful consideration of market conditions and company developments is advised before making investment decisions.